co-evolution broadly neutralizing hiv antibody founder virus
current human immunodeficiency virus hiv- vaccines elicit strain-specific neutralizing antibodies however cross-reactive neutralizing antibodies arise approximately % hiv--infected individuals details generation provide blueprint effective vaccination report isolation evolution structure broadly neutralizing antibody african donor followed time infection mature antibody ch103 neutralized approximately % hiv isolates co-crystal structure hiv envelope protein gp120 revealed new loop-based mechanism cd4-binding-site recognition virus antibody gene sequencing revealed concomitant virus evolution antibody maturation notably unmutated common ancestor ch103 lineage avidly bound transmitted/founder hiv envelope glycoprotein evolution antibody neutralization breadth preceded extensive viral diversification near ch103 epitope data determine viral antibody evolution leading induction lineage hiv broadly neutralizing antibodies provide insights strategies elicit similar antibodies vaccination
